Technology
Health
Biotechnology

Radius Health

$18.72
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.05 (0.27%) Today
+$0.05 (0.27%) Today

Why Robinhood?

You can buy or sell Radius Health and other stocks, options, ETFs, and crypto commission-free!

About

Radius Health, Inc. Common Stock, also called Radius Health, is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. Read More The company's lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes abaloparatide transdermal patch for potential use in osteoporosis and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Waltham, MA.

Employees
398
Headquarters
Waltham, Massachusetts
Founded
2003
Market Cap
850.67M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
762.50K
High Today
$18.91
Low Today
$18.63
Open Price
$18.67
Volume
42.84K
52 Week High
$37.66
52 Week Low
$12.81

Collections

Technology
Health
Biotechnology
Biopharmaceutical
Therapy
Cancer Prevention
Pharmaceutical
2014 IPO

News

Yahoo FinanceMar 1

Radius (RDUS) Posts Narrower Q4 Loss on Robust Tymlos Sales

Radius Health, Inc. RDUS reported encouraging results for the fourth quarter of 2018, wherein loss was narrower than expected and sales beat estimates. Radius Health, Inc. Price, Consensus and EPS Surprise Radius Health, Inc. Price, Consensus and EPS Surprise | Radius Health, Inc. Quote The company reported a loss of $0.66 per share in the quarter, narrower than both the Zacks Consensus Estimate of a loss of $0.82 and the year-ago period’s loss of $1.36. Increase in revenues led to the narrower-than-anti...

48
Seeking AlphaFeb 28

Radius Health, Inc. 2019 Q4 - Results - Earnings Call Slides

The following slide deck was published by Radius Health, Inc. in conjunction with their 2019 Q4 earnings call. 1 31 Click to enlarge Notes:...

1

Earnings

-$1.59
-$1.28
-$0.97
-$0.66
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Expected May 9, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.